Aperio Group’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-6,522
| Closed | -$861K | – | 2342 |
|
|
2018
Q4 | $861K | Sell |
6,522
-4
| -0.1% | -$512 | ﹤0.01% | 1391 |
|
|
2018
Q3 | $872K | Sell |
6,526
-468
| -7% | -$70.1K | ﹤0.01% | 1483 |
|
|
2018
Q2 | $1.11M | Buy |
6,994
+401
| +6% | +$59.5K | 0.01% | 1318 |
|
|
2018
Q1 | $943K | Buy |
6,593
+215
| +3% | +$29.4K | ﹤0.01% | 1357 |
|
|
2017
Q4 | $849K | Sell |
6,378
-216
| -3% | -$27.6K | ﹤0.01% | 1402 |
|
|
2017
Q3 | $820K | Sell |
6,594
-115
| -2% | -$15.8K | ﹤0.01% | 1388 |
|
|
2017
Q2 | $943K | Buy |
6,709
+641
| +11% | +$80.1K | 0.01% | 1269 |
|
|
2017
Q1 | $683K | Buy |
6,068
+1,215
| +25% | +$142K | ﹤0.01% | 1373 |
|
|
2016
Q4 | $511K | Buy |
4,853
+756
| +18% | +$81.3K | ﹤0.01% | 1503 |
|
|
2016
Q3 | $517K | Buy |
4,097
+691
| +20% | +$87.9K | ﹤0.01% | 1431 |
|
|
2016
Q2 | $470K | Sell |
3,406
-23
| -0.7% | -$3.04K | ﹤0.01% | 1425 |
|
|
2016
Q1 | $476K | Buy |
3,429
+357
| +12% | +$49K | ﹤0.01% | 1392 |
|
|
2015
Q4 | $495K | Buy |
3,072
+414
| +16% | +$64K | ﹤0.01% | 1344 |
|
|
2015
Q3 | $354K | Buy |
2,658
+633
| +31% | +$82.6K | ﹤0.01% | 1483 |
|
|
2015
Q2 | $232K | Buy |
2,025
+187
| +10% | +$22.4K | ﹤0.01% | 1781 |
|
|
2015
Q1 | $219K | Buy |
1,838
+195
| +12% | +$26K | ﹤0.01% | 1771 |
|
|
2014
Q4 | $239K | Buy |
+1,643
| New | +$206K | ﹤0.01% | 1642 |
|
Aperio Group's ATHN Position: Q1 2019 in Review
Aperio Group sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 6,522 shares — an estimated $861K sold.
Aperio Group first reported a position in ATHN in Q4 2014 and held it in 17 quarters. The position peaked at $1.11M in Q2 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- Aperio Group reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- Aperio Group sold 6,522 Athenahealth, Inc. shares in Q1 2019, an estimated $861K.
- Aperio Group first reported a position in Athenahealth, Inc. in Q4 2014 and held it in 17 quarters.
- Aperio Group's Athenahealth, Inc. position peaked at $1.11M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on Aperio Group's 13F filing for Q1 2019, filed 13 May 2019.